Nuvation Bio (NYSE:NUVB) Given New $6.00 Price Target at Royal Bank Of Canada
Nuvation Bio (NYSE:NUVB – Free Report) had its target price trimmed by Royal Bank Of Canada from $10.00 to $6.00 in a research note published on Tuesday,Benzinga reports. The firm currently has an outperform rating on the stock. Other equities analysts have also issued reports about the company. Citigroup began coverage on Nuvation Bio in […]
